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The glutathione/glutaredoxin system is made up of glutaredoxins, glutathione (GSH) and 
glutathione reductase (GLR). Glutaredoxins, which are involved in essential cellular 
functions such as DNA synthesis, iron metabolism and iron-sulfur cluster assembly, become 
oxidised during their catalytic cycle and are reduced by GSH and GLR. Glutaredoxins also 
play a critical role in regulating the glutathionylation/deglutathionylation cycle. Under 
oxidative stress conditions, protein thiols may be glutathionylated and glutaredoxin activity 
is important for restoring the functions of these proteins. While the individual components of 
this system have been studied extensively, the dynamics of the system as a whole has not 
been described despite its importance in the glutathionylation/deglutathionylation process. 
Computational systems biology approaches could be used to describe this type of regulation 
but the kinetic mechanism used by glutaredoxins for deglutathionylation is unclear as a 
monothiol and a dithiol mechanism have both been proposed for glutaredoxin activity. The 
in vitro data supporting these mechanisms have been contradictory with a number of 
discrepancies observed in the literature, including contrasting activities of mutant 
glutaredoxin Cxx(C→S) and wild-type glutaredoxins. Further, Lineweaver-Burk plots 
showed a curved line pattern in some studies, while other studies reported a linear pattern in 
response to GSH. Finally, analyses of the Lineweaver-Burk plots in two substrate kinetics 
experiments revealed both parallel line and intersecting initial velocity line patterns for 
deglutathionylation. Computational and mathematical models were used to resolve these 
discrepancies and we showed that the mono- and di- thiol mechanisms, are in fact identical. 
Mathematical models of mutant and wild-type glutaredoxin activities revealed that the GSH 
concentration and the rate constant for GSH oxidation significantly affected these relative 
activities which explained the contradictory data for wild-type and mutant glutaredoxins. 
The sigmoidal response to GSH was due to the kinetic order of this reaction and our results 
demonstrated that the resulting parallel and intersecting kinetic line patterns observed in 
some studies depended on the reversibility of the deglutathionylation reaction. Finally, 
fitting experiments showed that our models were able to accurately describe the in vitro data. 
Collectively, our results showed how deglutathionylation should be described in 
computational systems biology models and further revealed how the formation of oxidised 
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Chapter 1: Introduction 
 
1.1 Oxidative stress and diseases 
 
In aerobic organisms, oxygen is essential for survival as it is used for oxidative 
phosphorylation and is an important co-factor for several enzymatic reactions including the 
synthesis of the deoxyribonucleotides (Toledano et al., 2007; Kalyanaraman, 2013). 
Unfortunately, normal cellular metabolism generates reactive oxygen species (ROS) which 
can damage cellular components (Fig. 1.1; Cooke et al., 2003).  ROS may occur in the form 
of either free radicals, such as the highly reactive hydroxyl radical (OH•) or they may be non-
radicals such as hydrogen peroxide (H2O2) (Mates et al., 2010, 2012; Melis et al., 2013; Storr 
et al., 2013). These ROS are the major causes of oxidative stress which usually occurs as a 
result of an imbalance between ROS production and the scavenging activity of the cellular 
















Figure 1.1. The action of oxidative stress on the cellular components leading to disease 
and cell death (Cencioni et al., 2013). (Permission to reproduce this figure was granted by 




Oxidative stress poses an enormous risk to the survival of cells as it disrupts the redox 
homeostasis of the cell and may result in elevated levels of cellular damage, including 
oxidative DNA damage, alterations in the cytoplasmic and nuclear signalling as well as 
damage to lipids, carbohydrates and proteins (Fig. 1.1; Storr et al., 2013). Protein cysteinyl 
residues specifically are sensitive to oxidative stress which may result in the formation of 
cysteinyl radicals, sulfenic, sulfinic or irreversible sulfonic acids. Alternatively, adjacent 
sulfhydryl groups within a protein or adjacent proteins may form disulfide bridges resulting 
in changes in protein conformation and/or aggregation (Dalle-Donne et al., 2009).  The 
extensive damage caused by oxidative stress on cellular molecules has been recognised as the 
cause of several diseases and may accelerate processes such as aging (Fig. 1.2; Melis et al., 


















Figure 1.2. Diseases caused by the effect of oxidative stress  (Terlecky et al., 2012). 
(Permission to reproduce this figure was granted by Baishideng Publishing Group Inc.) 
 
Several diseases have been linked to oxidative stress-induced DNA mutation        
(Fig. 1.2; Cooke et al., 2003). DNA mutations induced by ROS may alter cellular signalling, 
leading to the inactivation of several tumour suppressor genes or alternatively, these 
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mutations may result in apoptosis which may be potentiated by ROS in many different cell 
types (Mates et al., 2008; Raj et al., 2011). Apoptosis is an important regulatory process in 
tumour expansion and the inhibition of apoptosis has been associated with many types of 
cancers (Kabore et al., 2004; Miura et al., 2011; Zhao et al., 2012). Interestingly, many 
cancer tumours have shown elevated amounts of oxidative stress lesions and studies have 
shown that the elevated levels of damage were due to the low amounts of antioxidant 
enzymes in relation to the high levels of ROS generation in the tumour environment 
(Toyokuni et al., 1995). Further, it has been shown that an increase in DNA damage together 
with the permanent activation of transcription factors and their associated genes resulting 
from elevated ROS creates a selection pressure for the malignant phenotype observed in 
cancer thus implicating oxidative DNA damage in the aetiology of cancer (Toyokuni et al., 
1995; Cooke et al., 2003). Thus, ROS play important but contradictory roles in both 
apoptosis and cancer (Mates and Sanchez-Jimenez, 2000). 
 
Oxidative stress has also been implicated in the pathogenesis of several 
neurodegenerative conditions (Fig. 1.2). Alzheimer’s disease for example, is a condition 
characterised by progressive dementia and affects a vast number of the aging population 
(Cooke et al., 2003). Oxidative stress in Alzheimer’s disease may be caused by an imbalance 
between radical detoxifying enzymes and the free radicals that are formed during oxidative 
stress (Butterfield et al., 2006; Gella and Durany, 2009). In affected patients, the brain tissue 
is exposed to elevated oxidative stress resulting in an excess of toxic ROS, numerous changes 
in cellular processes and the oxidation of DNA and RNA molecules (Fig. 1.1; Butterfield et 
al., 2006). Further, the reduction in brain and plasma antioxidant defence mechanisms 
strongly correlates with memory loss due to age (Butterfield et al., 2006; Gella and Durany, 
2009).  
 
Neurodegeneration as a result of oxidative stress has also been observed in patients 
with Parkinson’s disease. The primary cause of Parkinson’s disease is the advanced 
degeneration of neurons containing dopamine located in the zona-compacta of the substantia 
nigra (Alam et al., 1997). The connection between Parkinson’s disease and oxidative stress 
has been shown by various studies performed on post-mortem tissue where increases in iron 
levels (Sofic et al., 1988; Dexter et al., 1989; Riederer et al., 1989) and superoxide dismutase 
(SOD) activity (Saggu et al., 1989) were observed in the substantia nigra together with a 
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decrease in the levels of the thiol antioxidant GSH (Perry and Yong, 1986; Sofic et al., 1992; 
Sian et al., 1994).  
 
Inflammatory conditions, infections such as hepatitis C, as well as atopic dermatitis 
are also associated with elevated levels of oxidative lesions. ROS, particularly the superoxide 
anion and hydrogen peroxide, are produced during the respiratory burst of neutrophils, 
macrophages and eosinophiles as bactericidal species. These species cause damage to the 
surrounding tissues generating oxidative stress conditions (Cooke et al., 2003). These ROS 
are a major cause of connective tissue damage resulting in the formation of  modified 
biomolecules which can trigger autoimmune diseases such as rheumatoid arthritis and 
systemic lupus arythematosus (Fig. 1.2) which consequently have oxidative stress implicated 
in their pathogenesis (Cooke et al., 2003). 
 
1.2 Cellular protective mechanisms 
 
As oxidative stress is the basis for so many complications and diseases within cells, it 
is important that its effects are appropriately moderated. A number of proteins are responsible 
for regulating the levels of ROS within the cell as well as regulating redox-sensitive 
signalling pathways and maintaining a balance in the redox environment of the cell (Storr et 
al., 2013). These mechanisms can be broadly divided into non-thiol and thiol mechanisms 
although these mechanisms are closely integrated in vivo to protect cells against oxidative 
stress (Mates et al., 1999).  
 
1.2.1 Non-thiol antioxidant enzymes 
 
Superoxide dismutase (SOD) and catalase are the major non-thiol mechanisms used to 
counteract the effects of oxidative stress (Mates et al., 1999). Superoxide dismutase 
specifically, is important as it catalytically enhances the normal dismutation of the superoxide 
anion to hydrogen peroxide and oxygen (Fig. 1.3; Kalyanaraman, 2013; Storr et al., 2013). It 
increases the rate constant of normal dismutation from 105 M-1 s-1 to 109 M-1 s-1, thus lowering 
the ambient superoxide concentration (Kalyanaraman, 2013). Superoxide dismutase produces 
hydrogen peroxide as a primary product in its catalytic cycle, which in turn is detoxified by 










Figure 1.3. Activity of the three important cellular non-redoxin antioxidant defence 
enzymes, superoxide dismutase (SOD), catalase and glutathione (GSH) peroxidase.  
(This figure was adapted from Proctor and Reynolds, 1984)  
 
Catalase is an antioxidant enzyme, located in the peroxisomes of mammalian cells 
(Kalyanaraman, 2013) and converts hydrogen peroxide to water and oxygen (Fig. 1.3; Storr 
et al., 2013). Catalase is especially important in cardiovascular disease as it has been shown 
that the overexpression of catalase together with superoxide dismutase impedes the 
progression of atherosclerosis, one of the main health problems leading to cardiovascular 
morbidity and mortality (Storr et al., 2013).  
 
1.2.2 Thiol antioxidant mechanisms  
 
Thioredoxins, glutaredoxins and peroxiredoxins are the key components of the thiol 
redox systems that are involved in protecting the cells against ROS (Toledano et al., 2007; 
Storr et al., 2013). Thioredoxins and glutaredoxins are regarded as general disulfide 
reductases that also function in maintaining the thiol redox homeostasis of the cell (Trotter 
and Grant, 2003). Peroxiredoxins together with GSH peroxidases are ubiquitous non-heme 
peroxidases (Dayer et al., 2008) that play an important role in removing ROS from cells thus 
protecting the cell against oxidative stress (Wood et al., 2003). The activities of these 




Peroxiredoxins were discovered initially in yeast as enzymes providing protection 
against damage caused by oxidative stress (Kim et al., 1988). These redoxins were 
subsequently identified in many other biological kingdoms from bacteria to mammals and are 
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highly abundant in cells making up to 1% of the cellular protein content in some cells 
(Forman et al., 2010; Rhee et al., 2012). They are separated into three different classes, 1-
Cys, typical 2-Cys and atypical 2-Cys depending on the number of cysteine residues directly 
involved in catalysis (Chae et al., 1994; Wood et al., 2003). Typical 2-Cys peroxiredoxins are 
obligate homodimers containing two identical active sites (Hirotsu et al., 1999; Wood et al., 
2002) whereas the atypical 2-Cys peroxiredoxins are functionally monomeric (Seo et al., 
2000; Declercq et al., 2001). These proteins are localised mainly in the cytosol but certain 
isoforms can also be found in the mitochondria and nuclei (Wood et al., 2003). 
 
Saccharomyces cerevisiae has five different peroxiredoxin isoforms (Rhee et al., 
2003) whereas mammalian cells have six different isoforms with each peroxiredoxin 
possessing a conserved cysteine residue in the N-terminal region of the active site region of 
each isoform (Storr et al., 2013). Peroxiredoxins play a major role in the redox regulation of 
cell signalling and differentiation through the regulation of hydrogen peroxide levels within 
the cytosol (Rhee et al., 2012). They also function in the reduction of alkylhydroperoxides 
and peroxynitrites (Dayer et al., 2008). Furthermore, peroxiredoxins function as molecular 
chaperones and as phospholipase A2 enzymes (Chen et al., 2000; Hanschmann et al., 2013).  
 
 







Figure 1.4. Reaction mechanism of the peroxiredoxins. This cycle applies to both, 1-Cys 
and 2-Cys peroxiredoxins (Prx) and further shows the reducing activity of sulfiredoxins 
(Srx). (This figure was adapted from Jacob et al., 2004)  
 
Arguably the most significant function for peroxiredoxins is to reduce and detoxify 
hydrogen peroxide and organic hydroperoxides (ROOH) under oxidative stress conditions 
(Wood et al., 2003; Du et al., 2013). The N-terminal active site cysteine residue in 
peroxiredoxins (peroxidatic cysteine) reacts with either hydrogen peroxide or ROOH forming 
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a sulfenic acid intermediate in the partial reduction of these substrates to water or ROH 
respectively (Fig. 1.4; Hanschmann et al., 2013). The cysteine-sulfenic acid intermediate 
reacts with the C-terminal cysteine residue (resolving cysteine) that occurs in another subunit 
in the case of the typical 2-Cys peroxiredoxins, resulting in an intermolecular disulfide or 
intramolecular disulfide bond in the case of the atypical 2-Cys peroxiredoxins.  These bonds 
are reduced by thioredoxin in order to regain the active peroxiredoxin form (Wood et al., 
2003; Rhee et al., 2005; Lu and Holmgren, 2014). In the presence of excess peroxide, 
peroxiredoxins may become over-oxidised resulting in the formation of sulfinic as well as 
sulfonic acids on the N-terminal active site cysteine. Sulfonic acids are considered to be 
irreversible protein modifications under physiological conditions, but sulfiredoxins (Srx) 





Thioredoxins (Trx) were discovered in 1964 as essential cofactors for ribonucleotide 
reductase (RNR) (Laurent et al., 1964). Thioredoxin and thioredoxin reductase (TrxR) make 
up the thioredoxin system, which is essential in the regulation of the intracellular redox state. 
Thioredoxin is present in numerous species and possesses a conserved active site that is 








Figure 1.5. Scheme of the thioredoxin antioxidant system in the presence of oxidative 
stress. Oxidised thioredoxin (TRX) is reduced by thioredoxin reductase (TxrR) in the 
presence of NADPH and re-oxidised under oxidative stress conditions or during 
physiologically relevant reduction activities. (This figure was adapted from Akterin et al., 2006)  
 
In the thioredoxin system, electrons are transferred from NADPH through the activity 











this active site becomes oxidised (Fig. 1.5; Holmgren and Lu, 2010; Du et al., 2013) and 
thioredoxin reductase then recycles the disulfide back into its dithiol form (Fig. 1.5; 
Holmgren, 2000). Thioredoxins play an important role in the defence against oxidative stress 
by providing the necessary electrons for the peroxiredoxins in the cell. Interestingly, human 
Trx1 possesses three non-active site cysteine residues (Cys62, Cys69 and Cys 73) in addition 
to their active site which have been implicated in the regulation of the activity of this 
thioredoxin (Du et al., 2013). Under oxidising conditions, a second intramolecular disulfide 
distinct from the active site disulfide bond has been observed in these thioredoxins (Watson 
et al., 2003; Du et al., 2013) which disrupts the interaction that occurs between thioredoxin 
and its target proteins and inactivates Trx1 activity (Du et al., 2013). These non-active site 
cysteines may also possess the ability to transfer electrons to peroxiredoxins (Du et al., 
2013). In summary, thioredoxins work together with the peroxiredoxins in antioxidant 
activity, where peroxiredoxins use electrons donated by the thioredoxin in scavenging 













Figure 1.6.  Components of the thioredoxin and glutaredoxin system in Escherichia coli 
with arrows showing the flow of electrons to the processes and targets of these redoxins 
(Toledano et al., 2007). (Permission to reproduce this figure was granted by Elsevier publishing company) 
 
Thioredoxins as well as glutaredoxins (Grx) have been conserved throughout 
evolution and significant functional redundancy between these two systems has been 
recognised with regards to ribonucleotide reductase (RNR) which reduces ribonucleotides to 
deoxyribonucleotides (dNTPs), 3'-phosphoadenosine 5'-phosphosulfate (PAPS) reductase 
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(Fig. 1.6), and plasma GSH peroxidise activity (Lillig et al., 1999). The thioredoxin system in 
E. coli consists of two thioredoxins which are encoded by trxA and trxC and a thioredoxin 
reductase encoded by trxB (Fig 1.6; Miranda-Vizuete et al., 1997). The GSH/glutaredoxin 
pathway consists of GSH, glutathione reductase encoded by gor and three glutaredoxins, 
Grx1, Grx2 and Grx3 which are encoded by grxA, grxB and grxC respectively (Fig 1.6; 
Holmgren, 1976; Aslund et al., 1994). Normal aerobic growth is independent of either the 
thioredoxin or glutaredoxin branch individually, but when both systems are inactivated, cells 
are unviable as these systems are essential for ribonucleotide reductase activity (Fig. 1.6; 
Toledano et al., 2007). Another function of these pathways in the E. coli system was shown 
when trxA, gshA and grxA or trxA were mutated, resulting in the toxic accumulation of PAPS 
(Russel et al., 1990). PAPS is an intermediate of sulfur assimilation and is reduced to sulfite 
by PAPS reductase which in turn is reduced by thioredoxin or glutaredoxin.  Therefore, TrxA 
or Grx1 are necessary for sulfate assimilation and PAPS reductase reduction (Fig 1.6; 
Toledano et al., 2007). 
 
The cytosolic thioredoxin system in S. cerevisiae is made up of two thioredoxin 
genes, TRX1 and TRX2 and a thioredoxin reductase gene (Carmel-Harel and Storz, 2000).    
S. cerevisiae also has a GSH/glutaredoxin pathway performing similar functions to this 
thioredoxin pathway (Toledano et al., 2007). While single and double yeast thioredoxin 
mutants are viable, the double mutant showed an extended S-phase due to inefficient 
ribonucleotide reductase reduction (Toledano et al., 2007). This inefficiency has been 
established on the basis of a decrease in dNTP concentration as well as the reduced form of 
ribonucleotide reductase (Camier et al., 2007). These results showed that although the 
GSH/glutaredoxin pathway was able to perform ribonucleotide reductase reduction in yeast, 
it was not as efficient as the thioredoxin pathway (Toledano et al., 2007). Thioredoxins has 
been established as the sole hydrogen donor for PAPS reductase in S. cerevisiae, as the 
thioredoxin double mutant shows auxotrophy for sulfur amino acids (Draculic et al., 2000).  
 
Mammals have a large Trx-like protein (p23TrxL), a cytosolic Trx1 and a 
mitochondrial Trx2, all of which have a conserved active site (Storr et al., 2013). The 
thioredoxin system is essential for survival in mammalian cells and also performs similar 
functions to the glutaredoxins, including the common role as hydrogen donors for 
ribonucleotide reductase in DNA synthesis (Martin, 1995). Both these systems also function 
in the regulation of apoptosis (Saitoh et al., 1998; Chrestensen et al., 2000), redox regulation 
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of transcription factors such as NFκB and AP-1 (Schenk et al., 1994; Bandyopadhyay et al., 





Glutaredoxins were identified as GSH-dependent reductases when growth of a 
thioredoxin mutant of E. coli was observed suggesting that another protein was able to reduce 
ribonucleotide reductase (Holmgren, 1979b). Glutaredoxins are evolutionarily conserved, 
heat-stable oxidoreductases with active sites which contain one or two cysteine residues 
(Holmgren and Aslund, 1995). Depending on the number of cysteine residues at the CxxC/S 
active site, glutaredoxins can be separated into monothiol or dithiol type glutaredoxins 
(Herrero and de la Torre-Ruiz, 2007; Eckers et al., 2009). These glutaredoxins can further be 
grouped based on their physiological roles, subcellular localisation and biochemical 
properties (Eckers et al., 2009). They are structurally all members of the thioredoxin 
superfamily as they have a thioredoxin fold but are distinguishable from thioredoxins by their 
specificity for GSH (Luikenhuis et al., 1998; Eckers et al., 2009).  
 
As described above, while the GSH/glutaredoxin and thioredoxin systems are 
functionally redundant, E. coli double mutants lacking the components of both systems were 
not viable (Prinz et al., 1997; Toledano et al., 2007). Apart from the functions shared with the 
thioredoxin system (Fig. 1.6), glutaredoxins perform specialised functions within the cell, 
such as the reduction of arsenate reductase (ArsC) and the transcription factor OxyR 
(Fernandes and Holmgren, 2004). OxyR regulates the expression of Grx1, Trx2 and 
glutathione reductase (Gor; Fig. 1.6) and several other antioxidant defensive genes in 
response to increases in the hydrogen peroxide levels (Fernandes and Holmgren, 2004). In           
E. coli specifically, glutaredoxins also contribute to the defence against hydrogen peroxides 
with gshA and grxB mutants being more sensitive to hydrogen peroxide as shown by the 
elevation in carbonylation of intracellular proteins (Fernandes and Holmgren, 2004). 
 
The GSH/glutaredoxin pathway in  S. cerevisiae includes GSH, glutathione reductase 
(GLR) and two groups of glutaredoxins, the dithiol forms with a CxxC active site motif 
(GRX1, GRX2 and the putative GRX8) and the monothiol forms with a CxxS active site motif 
(GRX3, GRX4, GRX5, GRX6 and GRX7) (Toledano et al., 2007; Li et al., 2010). As with      
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E. coli, the viability of yeast cells is dependent on the presence of a single active glutaredoxin 
or thioredoxin system. The initial evidence of functional association between the thioredoxin 
and glutaredoxin systems in yeast arose from the recognition of a glutathione reductase non-
viable mutant when screening for mutations presenting a need for thioredoxins (Muller, 
1996).  
 
Table 1.1. Phenotypes and characteristics of thiol redox system mutants in 
Saccharomyces cerevisiae (Toledano et al., 2007). (Permission to reproduce this table was granted 












Baker’s yeast has provided an ideal eukaryotic organism for the analysis of the 
overlapping functions between the thioredoxin as well as the glutaredoxin systems (Draculic 
et al., 2000). The triple ∆trx1 ∆trx2 ∆glr1 mutant (Table 1.1) had limited growth, which was 
repaired by employing anaerobic conditions showing that the viability of this particular strain 
was strongly related to oxidative stress. It was further shown that the lethality of this mutant 
did not occur due to problems in the synthesis of deoxyribonucleotides because adding 
reduced GSH did not restore viability in this mutant (Grant, 2001). 
 
The functional overlap between the thioredoxin and the glutaredoxin systems was 
confirmed in other experiments. In the absence of both TRX1 and TRX2, there was an 
elevation in the levels of GSSG which shows an association between the thioredoxin system 
and the GSH levels in the cell (Muller, 1996). The ∆trx1 and ∆trx2 mutant triggered changes 
in the GSH:GSSG ratio and caused an elevation in both the GSH and the GSSG 
concentrations while the ∆glr1 mutant resulted in an increase in the GSSG concentration. 
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Thus, the high intracellular GSH/GSSG ratio may be maintained by thioredoxins together 
with glutathione reductase (Trotter and Grant, 2003).  
 
In mammalian cells glutaredoxins are involved not only in the reduction of 
ribonucleotide reductase but also in the reduction of dehydroascorbate (Wells et al., 1990) 
and are especially important in maintaining the reduced state of the cellular protein cysteine 
residues (Gladyshev et al., 2001). Glutaredoxins also play a key role in the 
glutathionylation/deglutathionylation cycle as described below. 
 
1.3 Glutathionylation  
 
The cysteinyl residues in proteins are particularly important in redox dependent 
modifications occurring during oxidative stress due to the sensitivity of the protein thiol 
group to oxidative alterations (Lillig et al., 2008). Excess hydrogen peroxide can lead to the 
formation of sulfinic acid (R-SO2H) or sulfonic acid (R-SO3H) which cannot be reduced by 
cellular redoxin systems (Fig. 1.7; Lillig and Berndt, 2013). However, under less extreme 
oxidative stress conditions, protein thiol groups may undergo modifications resulting in the 
formation of sulfenic acid  (R-SOH) and neighbouring protein thiols may form inter- or intra- 
molecular disulfide bonds between each other or with surrounding low molecular weight 









Figure 1.7. Reaction mechanism for the glutaredoxin system and the regulation of thiol 
modifications. (This figure was adapted from Lillig and Berndt, 2013)  
 
The process whereby the GSH attaches to the thiol groups of protein cysteine is called 
glutathionylation and glutathionylated proteins (RSSG) may have altered activities and/or 
structures (Fig. 1.7; Lillig et al., 2008; Dalle-Donne et al., 2009). Glutathionylation is 
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particularly important as it not only protects the protein cysteine residues from irreversible 
oxidation, where protein structural and functional changes remain permanent, but it also 
functions in regulating the activity of the many target proteins (Rouhier et al., 2004). The 
accumulation of glutathionylated proteins has been reported to occur under physiological and 
moderate oxidative stress conditions in various cell types, and GSH sometimes remains 
attached to the reactive cysteine residues of the intracellular proteins subsequent to the 
removal of the oxidative stress (Silva et al., 2008). Under these moderate stress conditions 
glutathionylation plays an important role in redox regulation; furthermore, the 
glutathionylation of abundant proteins may serve as storage for GSH (Dalle-Donne et al., 
2009).  
 
1.3.1 Target proteins of glutaredoxins  
  
Glutathionylation has been observed in various organisms including plants, E. coli, 
yeast and in mammals. In vivo and in vitro proteomic labelling of sensitive targets with 
biotinylated GSSG were used to identify many protein targets for glutathionylation (Table 
1.2; Rouhier et al., 2004). In plants for instance, glutathionylation plays a role in various 
fundamental processes such as flowering (Ogawa et al., 2001), root hair density and growth 
(Sanchez-Fernandez et al., 1997; Lillig et al., 2008). Plant proteins targets include aldolase 
(Ito et al., 2003), triose phosphate isomerase (Ito et al., 2003) and glutathione S-transferases 
(Dixon et al., 2002) amongst others (Table 1.2). In some plants there is interaction between 
the thioredoxin and glutaredoxin systems with the poplar thioredoxin h isoform (Ptrc trxh4) 
(Table 1.2) being reduced by plant glutaredoxins (Gelhaye et al., 2003) while the 
chloroplastic thioredoxin f (Table 1.2) is regulated by glutathionylation (Michelet et al., 
2005).  
 
In E. coli, the transcription factor OxyR was identified as a target protein for 
glutaredoxin and is able to go through a number of stable processes such as nitrosylation, 
oxidation resulting in the formation of an intramolecular disulfide and glutathionylation 
(Lillig et al., 2008) which result in post translational modifications of the regulatory thiol 
(SH). Changes in the structure, cooperative properties, DNA binding affinity as well as 
promoter activities of these altered forms of OxyR can be observed allowing for 










Aldolase (Ito et al., 2003) 
 Mitochondrial isoforms of thioredoxin h (Gelhaye et al., 2003) 
 
Chloroplastic f-type Trxs (Michelet et al., 2005) 
 Chloroplastic glyceraladehyde 3-phosphatase dehydrogenase 
(Zaffagnini et al., 2007) 
 Protein tyrosin phosphatase (Dixon et al., 2002) 
  
Escherichia coli targets OxyR (Zheng et al., 1998) 
 Ribonucleotide reductase  (Holmgren, 1979b) 
PAPS reductase (Lillig et al., 1999; Lillig et al., 2003) 




PTP1B (protein tyrosine phosphatase 1B) (Barrett et al., 1999)  
 NF-kB (nuclear factor kB) (p50 subunit) (Hirota et al., 2000; Klatt 
et al., 2000) 
 AP1 (activator protein 1)  (c-jun subunit) (Bandyopadhyay et al., 
1998; Zheng et al., 1998) 
 Caspase-3 (Klatt et al., 2000) 
 HIV protease (Davis et al., 1997) 
 Actin (Wang et al., 2001; Fratelli et al., 2002; Lind et al., 2002)  
 Glyceraldehyde 3-phosphate dehydrogenase (Lind et al., 2002) 
 Creatine kinase (Klatt et al., 2000) 
 Enolase (Fratelli et al., 2002; Lind et al., 2002)  
 Aldolase (Fratelli et al., 2002) 
  
Yeast targets Alcohol dehydrogenase (Klatt et al., 2000) 
Enolase (Shenton and Grant, 2003) 
GAPDH (Shenton and Grant, 2003) 
 
 
Numerous mammalian protein targets (Table 1.2) undergo glutathionylation 
especially under oxidative stress conditions (Rouhier et al., 2004). Interestingly, mammalian 
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glutaredoxins regulate peroxiredoxins and GSH peroxidase in response to oxidative stress 
and in so doing, regulate many transcription factors such as NF-kB, kinases and phosphatases 
in signalling pathways (Table 1.2; Rouhier et al., 2004).   
 
In yeast three protein targets for glutathionylation were recognised. With 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in particular, two of the three 
described isoforms were irreversibly glutathionylated (Shenton and Grant, 2003). The third 
isoform of GAPDH, unlike the other two, is inhibited by glutathionylation but can be restored 
by deglutathionylation activity of the monothiol Grx5. Furthermore, yeast mutants lacking 
Grx5 show increased GAPDH glutathionylation and an inhibition of enzyme activity 
(Shenton et al., 2002). In summary, a number of proteins involved in critical cellular 
processes may undergo glutathionylation (Table 1.2) emphasising how important the 
GSH/glutaredoxin system is within cells as a redox regulation mechanism (Dalle-Donne et 
al., 2009).  
 
1.3.2 Deglutathionylation of target proteins 
 
Glutathionylation of protein targets can be reversed by deglutathionylation (Shelton et 
al., 2005), where the GSH is removed from the thiol groups of protein cysteine residues, 









Figure 1.8. Deglutathionylation of a target protein by glutaredoxin (Grx). Reduced 
glutaredoxin (yellow circle) removes glutathione (GSH) from the glutathionylated 





This process of deglutathionylation is catalysed specifically by glutaredoxin in most 
organisms although it may also be catalysed by thioredoxins in yeast cells (Greetham et al., 
2010). Numerous dithiol glutaredoxins are capable of catalysing the GSH dependent 
reduction of disulfides or glutathionylated cysteines and are in turn reduced by GSH (Lillig et 
al., 2008). As the glutathionylation/deglutathionylation cycle (Fig. 1.8) is a significant 
mechanism in redox regulation and signalling and (Allen and Mieyal, 2012), systems biology 
approaches need to be developed in order to accurately study the dynamics of the 
glutaredoxin system in context of cellular function. 
 
1.4 Glutaredoxin dithiol and monothiol mechanisms in computational systems 
biology  
 
Computational modelling of the glutaredoxin system may offer an invaluable method 
to understand the regulation of this system as a whole and may provide a guide for wet 
laboratory analyses as they provide mechanistic details and allow for the testing and 
refinement of hypotheses on redox mechanisms (Pillay et al., 2013).  
 
In any systems biology modelling approach the first step is to clearly define the 
components to be studied. It was however not instantly evident whether the redoxins should 
be modelled as redox couples or as enzymes in computational models (Pillay et al., 2009). 
Redoxins could be modelled as redox couples as suggested by the use of redox potentials and 
ratios of oxidised to reduced redoxin to describe redoxins in vivo and in vitro (Aslund et al., 
1997). Alternatively, redoxin activity has been described using Michaelis-Menten kinetic 
parameters (Peltoniemi et al., 2006; Gallogly et al., 2008) suggesting that these redoxins 
could be modelled as enzymes. Recently, an analysis of the complete set of reactions in 
redoxin systems has provided a logical explanation for the discrepancies with the descriptions 
of redoxin activity presented in the literature. Using computational modelling, it was shown 
that redoxins should be accurately modelled as redox couples and that the enzymatic 
behaviour attributed to redoxins was due to saturation of the redox cycles within these 
systems (Pillay et al., 2009). However, a number of additional inconsistencies with the 
description of these redoxin activities have made the systems biology analysis of these 




For glutaredoxins particularly, two distinct mechanisms have been proposed in order 
to describe their activity using either one or both of the active site cysteines which make up 
the CxxC motif (Fig. 1.9). The monothiol mechanism requires only the N-terminal cysteine 
residue for the reduction of the GSH mixed disulfides whereas the dithiol mechanism 
proposes the use of both of the active site cysteine residues to reduce glutathionylated 
substrates. Interestingly, the dithiol mechanism is also used for the reduction of low 
molecular weight and protein disulfide substrates such as ribonucleotide reductase (Fig. 1.9; 

















Figure 1.9. Proposed mechanisms for glutaredoxin activity showing the 
deglutathionylation of glutathionylated protein (PSSG) mixed disulfides catalysed by 
glutaredoxins. The dithiol mechanism (A) shows the reduction of the intramolecular 
disulfide (GrxSS) at the active site of the glutaredoxins by 2 GSH molecules forming 
glutathione disulfide (GSSG) and recycling the reduced glutaredoxin (Grx-S-). The monothiol 
mechanism (B) shows the reduction of GrxSSG by GSH producing glutathione disulfide 
(GSSG) as the second product and recycling the reduced enzyme (Grx-S-) is considered the 
rate-determining step. Shown in reaction 4 of this mechanism is a connected side reaction 
which includes the formation of the intramolecular disulfide (GrxSS) at the active site of the 




A number of research efforts are focused on developing kinetic models of the 
glutaredoxin system (for example, Pillay et al., 2009; Adimora et al., 2010). However, 
models using either the monothiol and dithiol mechanism are expected to have different 
structural properties (Pillay et al., 2013) due to the difference in GSH stoichiometry and 
species in both mechanisms (Fig. 1.10 A-C). These differences will result in computational 
models with different sets of ordinary differential equations (ODEs) (Fig 1.10D) and models 
based on either mechanism are therefore likely to produce different behaviours for the same 
set of input parameters (Pillay et al., 2013). Resolving which mechanism should be used in 
















Figure 1.10. Proposed mechanisms for glutaredoxin activity. Depending on the 
mechanism, monothiol (A) or dithiol (B), the computational models based on these 
mechanisms will include either the GrxSHSSG/GrxSSG or GrxSS species (C), resulting 







1.5 Discussion  
 
Normal cellular processes cause the formation of reactive oxygen species, resulting in 
oxidative stress which may have negative effects on the cell and the organism as a whole. 
Many diseases such as cancer and Alzheimer’s disease are caused or aggravated by oxidative 
stress (Cooke et al., 2003). Cells have therefore developed non-redoxin and redoxin 
antioxidants in order to counteract the effects of oxidative stress. Redoxins in particular are 
very important as they are also responsible for the regulation of other processes within the 
cell (Storr et al., 2013). For instance, by regulating hydrogen peroxide levels in the cytosol, 
peroxiredoxins regulate cell signalling and differentiation. Thioredoxins and glutaredoxins 
are necessary for the reduction of numerous proteins and play an important role in DNA 
synthesis (Toledano et al., 2007; Du et al., 2013) 
 
Redox regulation is essential in cellular signalling and the changes in the redox state 
may lead to specific reversible oxidative modifications of important proteins (Jones, 2002, 
2006). The glutathionylation of proteins under conditions where the GSH:GSSG ratio is 
decreased, is both a protective and regulatory mechanism (Ruoppolo et al., 1997). 
Deglutathionylation seems to be generally mediated by glutaredoxins (Zaffagnini et al., 
2012) and is catalysed using one of two distinct mechanisms. In order to describe the 
dynamics of the GSH/glutaredoxin system using computational systems biology tools, we 
had to analyse the proposed mechanisms for deglutathionylation and determine which 
mechanism should be used in computational models. This basic research study can be used as 
a foundation to describe the roles played by glutaredoxin networks in a number of 
pathologies including cancer, and Mycobacterium tuberculosis and HIV infections (Gallogly 
and Mieyal, 2007).  
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Chapter 2: Additional discrepancies in the description of glutaredoxin 
deglutathionylation kinetics 
 
In addition to the differences between the monothiol and dithiol mechanisms (see 
Figure 1.9), a number of other discrepancies for the glutaredoxins activity have been reported 
in the literature and are described below. 
 
2.1 Discrepancy I: Activity of the Cxx(C→S) mutant  
 
In theory, a glutaredoxin Cxx(C→S) mutant in which one of the active site cysteines 
is mutated to a serine could provide a good test system for determining protein disulfide 
reduction mechanism and distinguishing between the monothiol and dithiol mechanisms as 
this mutant is unable to form an intramolecular disulfide (GrxSS), which is a major 
intermediate of the dithiol mechanism (Bushweller et al., 1992; Peltoniemi et al., 2006). 
Kinetic analysis showed that such mutants were inactive as hydrogen donors for 
ribonucleotide reductase (Bushweller et al., 1992) confirming that disulfide reduction follows 
a dithiol mechanism. However, the deglutathionylation activity data for these mutants was 
not as clear, as both higher and lower activities in the reduction of mixed disulfides have been 
reported.   
 
An E. coli glutaredoxin Cxx(C→S) mutant was used in the β-hydroxyethyl disulfide 
(HEDS) assay to measure GSH-dependent glutaredoxin activity. The HEDS or β-
mercaptoethanol (β-ME) disulfide assay is widely used to determine the specific activity of 
glutaredoxins (Holmgren, 1979a; Luikenhuis et al., 1998). In this assay GSH spontaneously 
reduces HEDS and yields β-ME as well as a mixed disulfide between β-ME and GSH (β-ME-
SG) (Lillig et al., 2008; Li et al., 2010). The addition of glutaredoxin to the β-ME-SG assay 
allows for reduction, resulting in β-ME and the formation of GrxSSG mixed disulfide. β-ME-
SG is then reduced using a monothiol or a dithiol mechanism (Lillig et al., 2008). The E. coli 
Cxx(C→S) glutaredoxin mutant retained only about 38% of the wild type glutaredoxin 
activity in the HEDS assay. Thus, in order for this glutaredoxin to be an effective reductant of 
glutathionylated substrates both active site cysteines were required (Bushweller et al., 1992; 
Xiao et al., 2005). Further, other investigations also showed that the wild type E. coli 
glutaredoxin had a higher reductase activity than the corresponding mutant glutaredoxin for 
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the reduction of an RNase-SG mixed disulfide (Xiao et al., 2005). Similar results were 











Figure 2.1. Comparison of mammalian wild type (●) and mutant (■) glutaredoxin 
activity using cysteine-glutathione disulfide (CSSG) (Gallogly et al., 2008). (Permission to 
reproduce this figure was granted by American Chemical Society)   
 
In contrast, a mammalian Grx2 mutant for was shown to have an enhanced 
deglutathionylation activity compared to wild-type Grx2 when cysteine-glutathione disulfide 
(CSSG) was used as a substrate. The result showed that only the N-terminal cysteine residue 
was necessary in this reaction and that the formation of the glutaredoxin disulfide detracted 
from catalysis (Fig. 2.1; Gallogly et al., 2008). An interesting observation from these studies 
was that as GSH concentration increased the turnover of the wild type glutaredoxins became 
equal to that of the mutant (Fig. 2.1; Gallogly et al., 2008). The reasons for these 
contradictory reports for glutaredoxin mutant and wild-type activity had not been elucidated. 
 
2.2 Discrepancy II: GSH stoichiometry  
 
The mono- and di- thiol reaction schema for deglutathionylation suggested that the 
different GSH stoichiometry involved in both mechanisms could also be used to distinguish 
them (Fig. 1.9; Gallogly et al., 2008). As the monothiol mechanism makes use of only one 
GSH molecule per reaction event, a linear response to the changes in GSH concentration 
would be expected. On the other hand, as the dithiol mechanism utilises two GSH molecules 
per reaction, a non-linear rate response to changes in GSH concentration would be expected. 














Figure 2.2. Analysis of changes in the rate of reaction of GSH concentration in 
glutaredoxin-catalysed peptide deglutathionylation in Escherichia coli with inset 
showing a Lineweaver-Burk plot of this reaction profile (Peltoniemi et al., 2006). 
(Permission to reproduce this figure was granted by The American Society for Biochemistry and Molecular 
Biology) 
 
In studies with E. coli Grx1 and a glutathionylated peptide, a sigmoidal increase was 
observed in the initial rate with increasing GSH concentrations and the resulting Lineweaver-
Burk plot was non-linear and did not fit to the Michaelis-Menten equation, but instead 
showed a curved shape (Fig. 2.2; Peltoniemi et al., 2006). A sigmoidal rate dependence on 
substrate concentration normally implies substrate co-operativity but is unlikely as the 
glutaredoxins are small molecules and have a single GSH binding site. These authors 
postulated that the sigmoidal shape was probably due to the effect of the Grx-GSH mixed 
disulfide intermediate alternating between the formation of reduced (GrxSH) or oxidised 
glutaredoxin (GrxSS) and the re-reduction of oxidised glutaredoxin by GSH. Interestingly 
oxidised glutaredoxin was a prominent species in quenched-flow experiments used to trap the 
deglutathionylation reaction intermediates in these experiments, and has been detected in vivo 
(Trotter and Grant, 2003; Peltoniemi et al., 2006). Collectively, this observed kinetic pattern 
agreed with the expected pattern for the dithiol mechanism. However, others studies have 
indicated that deglutathionylation followed a linear dependence on GSH concentration 


























Figure 2.3. Different kinetic patterns for deglutathionylation were obtained with 
different substrates.   Reciprocal plots for rate against changing concentration of CSSG and 
BSA-SSG showed ping-pong patterns (A and B) (Gallogly et al., 2008) while a sequential 
pattern was obtained with the Lineweaver-Burk plots for GSH and HEDS (C and D) (Mieyal 
et al., 1991). (Permission to reproduce these figures was granted by American Chemical Society)   
 
The glutaredoxin-mediated thiol/disulfide exchange reactions involving the 
glutaredoxin/glutathione mixed disulfide (GrxSSG) was expected to give a ping-pong kinetic 
pattern because the data indicated that the reduction and oxidation of glutaredoxins occurred 
independently of each other (Gallogly et al., 2009). This pattern was indeed observed in 
studies with the substrates CSSG and BSA-SSG (Fig. 2.3 A-B). However, studies revealed a 
sequential pattern where intersecting lines were obtained for both GSH and HEDS substrate 
A  B 
 D  C 
1/[GSH], mM -1 1/[HEDS], mM -1 
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in double reciprocal plots (Fig 2.3 C-D; Mieyal et al., 1991). It was proposed that these 
sequential patterns may occur as a result of simultaneous binding of GSH and glutaredoxin to 
the substrate, where preincubation of the substrate with GSH forms a glutathionylated 
substrate which is in turn reduced by the glutaredoxin (Mieyal et al., 1991; Gravina and 
Mieyal, 1993; Mesecke et al., 2008; Deponte, 2013). However, no data supporting this 




 Apart from the structural differences in the mono- and di- thiol mechanisms (Table 
2.1), a number of other inconsistencies exist in the literature on glutaredoxin activity, as 
summarised in the preceding sections. The discrepancies include the observed differences in 
the activity of the glutaredoxin mutant Cxx(C→S) compared to the wild type glutaredoxin 
(Mieyal et al., 1991; Bushweller et al., 1992; Gallogly et al., 2008) and the observation of 
hyperbolic  and sigmoidal patterns in kinetic rate plots resulting in both linear and curved line 
patterns in double reciprocal plots in response to GSH (Mieyal et al., 1991; Peltoniemi et al., 
2006; Gallogly et al., 2009). Additional discrepancies were also observed in the kinetic 
patterns, with two-substrate kinetic experiments showing both ping-pong and sequential 
kinetic patterns for glutathionylated substrates (Mieyal et al., 1991; Gallogly et al., 2009). It 
was therefore important to also resolve these discrepancies in addition to determining the 
mechanism used in the deglutathionylation process, before developing computational systems 
biology models of this particular system. 
 
Table 2.1. Summary of differences in the dithiol and monothiol mechanisms. 
Monothiol Mechanism Dithiol Mechanism 
 
 Cannot be used in catalysis of protein 
disulfide reduction. 
 Catalyses the reduction of protein 
disulfides. 
 Formation of the intramolecular 
disulfide (GrxSS) is a side reaction.  
 Intramolecular disulfide (GrxSS) is 
central to catalysis. 
 Changes in the rate of reaction with 
GSH concentration showed a linear 
response. 
 Changes in the rate of reaction with 




Chapter 3: Resolving the discrepancies in the description of 
glutaredoxin kinetics with computational models  
 
3.1 Introduction  
 
As described in the previous chapter, the in vitro descriptions of the 
GSH/glutaredoxin system have resulted in discrepancies which have complicated the 
development of computational models for this system. The construction of kinetic models is 
progressively becoming more essential in redox biology for the quantification as well as for 
understanding the complexity of regulation of these systems in living cells (Pillay et al., 
2013). However, while computational and mathematical models are useful in describing 
complex biological systems, they can also be used to resolve discrepancies in kinetic data sets 
(Pillay et al., 2013). In this section, we show how the GSH/glutaredoxin system can be 




3.2.1 Kinetic Modelling  
 
Kinetic modelling experiments were carried out using the Python Simulator for 
Cellular Systems (PySCeS) (Olivier et al., 2005). Previous studies from our group showed 
that the saturation of the redox cycles in the GSH/glutaredoxin system caused the enzyme-
like behaviour attributed to glutaredoxins and that mass action kinetics was sufficient to 
describe the glutaredoxin activity (Pillay et al., 2009). Therefore the glutaredoxin oxidation 
and reduction reactions were modelled using mass action kinetics while the glutathione 
reductase reaction was modelled with the irreversible form of a generic two-substrate rate 
expression (Rohwer et al., 2006). 
 
Core models with mass-action kinetics for the mono- and di- thiol mechanisms 
(Appendix 1; Pillay et al., 2009) were parameterized using a basic kinetic parameter set to 
investigate the generic properties of these models (Table 3.1). Realistic models, incorporating 
realistic rate-expressions were parameterized using kinetic parameters from the BRENDA 
database (www.brenda-enzymes.org) or from the biochemical literature, and were fitted to in 
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vitro datasets using non-linear least squares regression with the Levenberg–Marquardt 
algorithm which is available through the SciPy library of scientific routines 
(http://www.scipy.org).  
 
For the fitting experiments the dithiol mechanism was used to generate the model data 
(Appendix 1) which was fitted to in vitro datasets. The mono- and di- thiol mechanisms were 
modelled according to Fig 1.10 (C) with the models of these mechanisms having three 
reactions each. The first reaction for both mechanisms was the reduction of GSSG by 
glutathione reductase in the presence of NADPH, followed by the reduction of the 
intermediate GrxSSG by GSH in the monothiol mechanism or the reduction of oxidized 
glutaredoxin (GrxSS) in the dithiol mechanism. Both models included the deglutathionylation 
of a protein substrate (PSSG) by reduced glutaredoxin (GrxSH)2. The purported side reaction 
involving oxidized glutaredoxin (GrxSS) in the monothiol mechanism was omitted from this 
model as it is not considered central to catalysis in this mechanism (Mieyal et al., 2008; 
Deponte, 2013; Appendix 1). 
 
3.3 Results  
 
3.3.1 Computational models based on the dithiol and monothiol mechanisms give 
distinct results   
 
Time course simulations were undertaken to analyse the changes in species 
concentration over time for both the monothiol and dithiol models using realistic parameter 
values (Gallogly et al., 2008; Table 3.1). The monothiol mechanism includes the side 
reaction forming the intramolecular glutaredoxin (GrxSS) therefore distinguishing it from the 
mutant mechanism which cannot go through this reaction. The side reaction was however not 
included in the monothiol model. These time course simulations showed that both the 
monothiol and dithiol models were able to reach a steady state. In the monothiol mechanism 
two GSH molecules are released by glutathione reductase but only one GSH molecule is 
consumed in the deglutathionylation reaction (Appendix 1).This imbalance was resolved by 
modelling one of the GSH molecules in the first reaction (Fig. 3.2) as a fixed species as it is 
released from substrate PSSG. This species was expected to be present in smaller quantities 
27 
 
in relation to the free GSH in in vitro assays and within the cell (Peltoniemi et al., 2006; 
Gallogly et al., 2008).  
 
Table 3.1. Parameters and values for core monothiol and dithiol models used in the time 
course simulation experiments for the analysis of glutathione/glutaredoxin systems. 
 
Similarly, the dithiol mechanism showed that two GSH molecules are also released by 
glutathione reductase and both molecules are used in the deglutathionylation reaction. 
However, a further GSH molecule is liberated from the deglutathionylation of the substrate. 
This imbalance in this case was also resolved by modelling the GSH molecule liberated in 
this reaction as a fixed species GSHp (Fig 3.2). The time course simulations showed that the 
 Values  Reference  
 Monothiol Dithiol  
Fixed Metabolites (µM) (µM)  
NADPH 200 200 Gallogly et al., 2008 
NADP 1 1 Gallogly et al., 2008 
PSSG 40 40 Gallogly et al., 2008 
PSH 1 1 Gallogly et al., 2008 
GSHp - 1  
Variable Species (µM) (µM)  
GSH 500 998 Gallogly et al., 2008 
GSSG 500 1 Gallogly et al., 2008 
Grx(SH)2 0.0675 0.0675 Gallogly et al., 2008 
GrxSS - 0.0675 Gallogly et al., 2008 
GrxSSG 0.0675 - Gallogly et al., 2008 
Kinetic Parameters    
KNADPH 8 µM 8 µM Worthington and Rosemeyer, 1976 
KGSSG 65 µM  65 µM Worthington and Rosemeyer, 1976 
k cat 210 s
-1 
210 s
-1 Worthington and Rosemeyer, 1976 
k2 5.12e
-5 5.12e-5 - 
k3 0.054 0.054 - 
[Glutathione reductase] 0.02 µM 0.02 µM Gallogly et al., 2008 
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dithiol model was also able to achieve steady state (Fig. 3.1 B, D). Despite having the same 
input parameters these models gave different results, as discussed in chapter 1.   
 
Monothiol      Dithiol 


















Figure 3.1. Time course simulations of the glutathione/glutaredoxin system using the 
monothiol (A and C) and dithiol (B and D) mechanisms with models of core parameter 
datasets (Table 3.1). Changes observed in the; GSH (solid line) and GSSG (Dashed line) 
(A), GrxSS (solid line) and GrxSH (dashed line) (B), GSH (solid line) and GSSG (Dashed 




Figure 3.2. The dithiol and monothiol mechanisms (A) result in unbalanced ordinary 
differential equations (ODEs) (B). In the monothiol mechanism, the ODE for the 
glutathione moiety couple (GSH+GSSG) was balanced by modelling the GSH liberated from 
the substrate as GSHp in reaction (1) (Red) and the side reaction (GrxSSG → GrxSS + GSH) of 
the monothiol mechanism showing the formation of intramolecular glutaredoxin was not 
included in the model; in the dithiol mechanism the GSH liberated from the substrate is also 
treated as a separate species and modelled as GSHp in reaction (6) (Blue). 
 
3.3.2 The dithiol and monothiol mechanisms are functionally equivalent 
 
A central difference in the monothiol and dithiol mechanisms was the formation of a 
GrxSSG intermediate in the monothiol mechanism and not in the dithiol mechanism (Fig. 
3.2). However, this mixed disulfide intermediate does feature in the dithiol mechanism if the 
reduction of the glutathionylated protein (PSSG) and reduction of oxidized glutaredoxin are 
carefully considered (Fig 3.3A). Another expected difference between the mechanisms was 
the formation of the intramolecular (GrxSS) disulfide, which was considered a side reaction 
in the monothiol mechanism but central to the dithiol mechanism (Fig 3.3B). However, once 
this side reaction was included in the monothiol mechanism, the two mechanisms were 
identical (Fig. 3.3), contrasting to the current literature on this system (see for example 
Gallogly et al., 2008; Mieyal et al., 2008; Deponte, 2013). While the oxidized glutaredoxin 
intermediate (GrxSS) has been detected in in vitro (Peltoniemi et al., 2006) and in vivo 
A                                                                                      B  
Scheme I: Monothiol mechanism 
NADPH + GSSG → NADP
+ 
+ GSH + GSHp    (1) 
GrxSSG + GSH → Grx(SH)2 + GSSG                    (2) 
PSSG + Grx(SH)2 → PSH + GrxSSG                 (3) 
 
 
Ordinary Differential Equations  
dGSSG/dt          = - v1 +  v2 
dGSH/dt           =  v1 - v2 
dGrxSSG/dt       = - v2 + v3 
dGrx(SH)2/dt       = v2 - v3 
 
Scheme II: Dithiol mechanism  
NADPH + GSSG → NADP
+ 
+ 2 GSH                 (4) 
GrxSS + 2 GSH → Grx(SH)2 + GSSG                  (5) 
PSSG + Grx(SH)2 → PSH + GrxSS + GSHp         (6) 
 
Ordinary Differential Equations 
dGSSG/dt       = - v4+  v5 
dGSH/dt         = 2v4 - 2v5 
dGrxSS/dt       = -v5 + v6 
dGrx(SH)2/dt   = v5 -  v6  
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experiments (Trotter and Grant, 2003) GrxSSG could not be trapped in these experiments 
suggesting that it is a transient species and we will therefore not explicitly model it. The 
functional equivalence of the two mechanisms (Fig. 3.3) gave us a framework to tackle the 
















Figure 3.3.  The proposed dithiol mechanism (A) is functionally equivalent to the 
monothiol mechanism (B). The deglutathionylation of PSSG mixed disulfides by reduced 
glutaredoxins Grx(SH)2 showing the formation of the glutaredoxin mixed disulfide (GrxSSG) 
intermediate in both mechanisms (red) is followed by the reduction of oxidised glutaredoxin 
(GrxSS) by GSH (blue). The overlap of reactions (purple) occurs because the formation of 








3.3.3 Computational models of deglutathionylation can capture the in vitro kinetic 
behaviour accurately  
 
On the basis that glutaredoxins were enzymes, a number of standard kinetic analyses 
of the GSH/glutaredoxin system have been undertaken. Michaelis-Menten parameters for 
glutaredoxin using glutathionylated substrates were determined using substrate saturation 
curves and Lineweaver-Burk reciprocal plots, and the effect of increasing glutaredoxin 
concentration on rate was also determined. In these analyses kinetic datasets were fitted to the 
Michaelis-Menten equation and the relevant Km and kcat parameters were determined (see for 
example Peltoniemi et al., 2006; Gallogly et al., 2008).  
 
Computational experiments were therefore undertaken to see whether our dithiol core 
model with mass action kinetics could capture these in vitro kinetic behaviours (Fig. 3.4). In 
our modelling experiments, a classical saturation curve was observed for the substrate 
(PSSG) (Fig. 3.4 A). The initial rate of reaction for the substrate PSSG increased with the 
increasing concentration and thus the Lineweaver-Burk plot for PSSG reduction showed a 
linear dependence with increasing PSSG concentrations (Fig. 3.4 B). For the GSH saturation 
curve, the computational modelling results showed an increase in initial rate followed by 
saturation in the system (Fig 3.4 C). However the curve did not fit to the Michaelis-Menten 
equation and instead showed a curved line pattern in a Lineweaver-Burk plot (Fig. 3.4 D). 
This effect was postulated to be due to the net effect of the partitioning of the glutaredoxin-
GSH mixed disulfide intermediate between the formation of reduced or oxidised 
glutaredoxins and the re-reduction of oxidised glutaredoxin by GSH (Peltoniemi et al., 2006). 
However, this explanation was not clear and in our model, the sigmoidal dependencies of rate 
on GSH can be readily explained by the fact that two molecules of GSH are used for each 
reduction of oxidized glutaredoxin (GrxSS). Thus, the reaction order for this reaction is two 
(Equation 5; Scheme II, Fig 3.1). Finally there was a quasi-linear dependence of the initial 
deglutathionylation rate on the concentration of glutaredoxin (Fig. 3.4 E). Collectively these 
results showed that our computational modelling approach was consistent with the in vitro 
































Figure 3.4. Analysis of kinetic behaviour of a realistic dithiol model (Table A1; 
Appendix 2) as a function of glutathionylated protein substrate (PSSG) (A) with the 
double-reciprocal Lineweaver-Burk plot for PSSG (B); as a function of the 
concentration of GSH (C) with the double-reciprocal Lineweaver-Burk plot (D); and as 




3.3.4 Grx Cxx(C→S) mutant and wild-type glutaredoxin kinetic studies showed that 
differences in activity is dependent on the rate of GSH oxidation  
 
Core mathematical modelling was used to resolve the discrepancies in activities for 
reported wild type and mutant glutaredoxin. The dithiol mechanism (Scheme II) was used to 
represent the wild-type glutaredoxin with mass-action kinetics used to describe the reactions 
of this mechanism in the mathematical model (Pillay et al., 2009).  
 
To build this mathematical model, we focused on the reactions that showed the 
reduction of intramolecular disulfide (GrxSS) (equation 5) and the reduction of 
glutathionylated protein substrate (equation 6). The model consisted of a series of rate 
equations (equations 7-8) describing the kinetics of the glutaredoxin redox cycle (Scheme II; 
equations 7-8) and the sum of the glutaredoxin moiety couple (equation 9). 
  
                     (7) 
               
   (8) 
                      (9) 
 
At steady state v1 = v2, and therefore: 
                             
  (10) 
Rearranging equation (10) yielded the following equation: 
      
             
             
                           (11) 
Equation (11) was substituted into equation (10) to give the following expression for the rate 
of the wild-type (wt) mechanism: 
     
             
 
    
  
 
    
  
 
      
 
     
  
 
      
 (12) 
A similar set of equations was derived for the mutant. The reduction of the 
glutaredoxin mixed disulfide (GrxSSG) and the reduction of glutathionylated protein 
substrate were considered and the model consisted of a series of rate equations describing the 
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kinetics of these reactions. Equation (15) described the sum of the glutaredoxin moiety 
couple. 
 
The reactions of the mutant mechanism were described by the following equations: 
                 (13) 
     
             (14)  
                    (15) 
 
The rate constants for the glutathione oxidation (v2) are different for wild-type (  , M
-2min-1) 
and mutant (  
 , M-1min-1) redoxins and were therefore not directly comparable. 
 
Again, at steady state v1 = v2 and therefore: 
                
             (16) 
Rearranging equation (16) yielded equation (17): 
       
            
         
     
                          (17) 
Equation (17) was substituted into equation (16) to give the following expression for the rate 
of the mutant (mu) mechanism: 
     
             
    
  
  
   
  
 




   
 
 
      
 (18) 
In order to compare the mechanisms, equation (12) could be divided by equation (18) 
yielding equation (19) which represents the ratio of the rates of the two mechanisms.  
    





   
 
 
      
 
     
  
 
      
 (19) 
The term k1.PSSG represents the reduction of the reduction of PSSG. For substrate 
concentrations that are high (k1.PSSG>>1), and equation (19) simplifies to: 
    
    
 
     
  




This simple mathematical model showed that at high substrate concentrations the 
difference in rate between the wild-type and mutant glutaredoxin can be described largely by 
the differences in the rate constants k2 and k2' for GSH oxidation. In vitro data by Srinivasan 
and colleagues (1997) showed that in glutaredoxin dependent reactions the GSH oxidation 
step is indeed the rate limiting step of the deglutathionylation reaction supporting our 
mathematical model. If the active site mutant has an increased rate constant for the oxidation 
of GSH (  
  >    GSH), then the mutant could have higher activity compared to the wild type 
glutaredoxin. However, with increases in the glutathione concentration, equation (20) 
predicts that the relative rate of wild-type to mutant will increase. This has been confirmed by 
in vitro data with human Grx2 (cf. Fig. 2.2; Gallogly et al., 2008) where mutant and wild-
type rates became equivalent at high glutathione concentrations. 
 
3.3.5 Reciprocal plot kinetics depend on the reversibility of the deglutathionylation 
reaction 
 
 Double-reciprocal kinetic plots for glutaredoxins have shown confusing data for 
deglutathionylation with some studies reporting a sequential mechanism while others have 
described a ping-pong mechanism. To understand this behaviour the standard ping-pong rate 
expression (equation 21) was compared to the rate expression for the wild-type glutaredoxin 
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According to this analysis, the gradient of the line (k1/Grx tot, see equation 22) when 
plotting 1/v2wt against 1/PSSG is not affected by the changes in concentration of reduced 
glutathione (GSH). Therefore, the reciprocal plots of reaction rate against PSSG would result 
in a parallel line pattern (as normally observed for a ping-pong mechanism). However, in 













Figure 3.5. Two substrate kinetic pattern for a core dithiol model of glutaredoxin 
showing the dependence of glutaredoxin activity on glutathionylated substrate (PSSG) at 
various concentrations of GSH: black (0.25 µM) blue (0.30 µM) red (0.40 µM) and green 
(0.60 µM) (A), and the dependence of activity on GSH concentration at various 
concentrations of glutathionylated protein substrate (PSSG): black (0.00025 µM) blue 
(0.00030 µM) red (0.00040 µM) and green (0.00060 µM) (B). 
 
To confirm this mathematical modelling result, reciprocal plot kinetics were obtained 
with the wild-type mechanism model. The expected ping pong kinetic pattern for the 
reciprocal plot showing rate against the reduction of glutathionylated protein substrate 
(PSSG) was indeed obtained (Fig. 3.5 A). The double reciprocal plot for GSH resulted in a 
curved line pattern (Fig 3.5 B) which was observed in the in vitro experiments (Peltoniemi et 
al., 2006). However, a linear response of 1/v to 1/GSH was obtained in some two substrate 
kinetic in vitro studies (Mieyal et al., 1991; Gallogly et al., 2008). In these experiments only 
a few data points were used and the points chosen lay within the quasi-linear region of the 
curve (high 
 




We next needed to determine the cause of the sequential pattern observed in some two 
substrate in vitro experiments. It was noted that the sequential patterns were observed in 
reciprocal plots where HEDS was used as a substrate. HEDS, as previously explained, reacts 
spontaneously with GSH forming the glutathionylated substrate β-ME-SG. However, in 
contrast to other glutathionylated substrates, the substrate can subsequently be reformed by 
the reaction of these products, and therefore this reaction was significantly reversible in the 
conditions described in these in vitro assays (Gravina and Mieyal, 1993). To investigate 
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whether this was important, the deglutathionylation reaction (reaction 6, Scheme II, Fig. 3.2), 
was modelled with reversible kinetics, using a Keq value of one for the reduction of the 
glutathionylated substrate.  
 
 


















Figure 3.6. Two substrate kinetic experiments showing ping-pong and sequential 
patterns obtained for glutaredoxin dependent deglutathionylation reaction (Table A1; 
Appendix 2). The deglutathionylation reaction for fixed glutathionylated substrate (PSSG) at 
various concentrations of GSH, yellow (250 µM) blue (300 µM) red (400 µM) and green 
(600 µM) was modelled with reversible (solid) and irreversible (dashed) kinetic expressions 
(A), then a double log plot (B), and reciprocal plots (C-D) were generated for these different 
datasets.  
 
When reversible and irreversible kinetics were compared (Fig. 3.6A), the differences 
in the initial reaction rates between increasing GSH concentrations and at lower PSSG 
concentrations were quiet significant (Fig.3.6B). The change from a reversible to an 
irreversible kinetic rate expression, led to change from a sequential pattern (Fig 3.6C), to the 
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observed ping-pong pattern (Fig. 3.6D). Our results showed that this resultant ping-pong 
pattern was due to the similarity of the initial rates of reaction for each PSSG concentration 
and thus when the reciprocal plot was generated, these rates shifted in such a way that the 
pattern showed parallel lines. On the other hand, with the use of the reversible kinetic rate 
expression the difference in the initial rate of reaction for each concentration of PSSG 
became exaggerated in the reciprocal plot (high 1/PSSG) which then resulted in the apparent 
sequential pattern, thus resolving this discrepancy in the literature.  
 
3.3.6 Fitting in vitro datasets to the dithiol model  
 
To further validate our dithiol kinetic modelling, several realistic in vitro kinetic 
datasets were fitted to a glutaredoxin model (Scheme II). The equilibrium constant (Keq) for 
the reduction of the intramolecular glutaredoxin (GrxSS) in the dithiol mechanism    
(Appendix 1) was determined from the redox potentials of the glutaredoxin (-236mV) and 
GSH (-240mV) redox couples (Aslund et al., 1997). The equilibrium constant for 
deglutathionylation of some of the substrates was unknown and so these reactions were 
modelled with irreversible kinetics.      
 
                                                                                                                                           







Figure 3.7. A kinetic model of the Escherichia coli glutaredoxin system (continuous line) 
was fitted on in vitro datasets (●) describing the deglutathionylation of a peptide (PSSG) 
(Peltoniemi et al., 2006). The r2 value was determined to be 0.990 with the rate constant for 
reduction of glutaredoxin by glutathione determined as 4.76x10-06 ± 2.99x10-07 µM-2.s-1 and 
the rate constant for the reduction of PSSG by glutaredoxin determined as                           




The rate constants for the glutaredoxin system were determined by fitting the kinetic 
model to experimental datasets. For E. coli glutaredoxin, the kinetic model showed an 
excellent fit to a dataset describing reduction of a glutathionylated peptide substrate (PSSG) 
with an r2 value of 0.990 (Fig. 3.7). The rate constants for PSSG reduction (k3) was            
0.66 ± 0.046 µM-1.s-1 while the rate constant for glutaredoxin reduction (k2) was          
4.76x10-06 ± 2.99x10-07 µM-2.s-1 
 
Fitting experiments were also done for yeast glutaredoxin using various in vitro 
datasets. We first fitted our kinetic model to datasets showing the reduction of HED with 
Grx1 and Grx2. The model fitted the data with r2 values of 0.944 and 0.955 for Grx1 and 
Grx2 respectively (Fig. 3.8 A, B) with rate constants for Grx1 determined as               
4.23x10-06 ± 2.99x10-07 µM-2.s-1 and 0.07 ± 0.012 µM-1.s-1 for k2 and k3 respectively, and for 
Grx2, k2 was 7.07x10
-05 ± 1.19x10-05 µM-2.s-1 and k3 was 0.30 ± 0.057 µM
-1.s-1. These results 
were not too surprising as these relatively lower r2 values could be explained by the fact that 
in our model this reduction reaction was modelled with irreversible kinetics as the 
equilibrium constant for the reaction was not known.  
 
We then looked at a different dataset which showed the change in the rate of 
oxidation of GSH by S. cerevisiae Grx1 with a HED substrate. This fitting experiment also 
showed a good fit with an r2 value of 0.989 in the comparison between the model and the in 
vitro data (Fig. 3.8C; Discola et al., 2009) with rate constants determined as                 
1.18x10-05 ± 6.25x10-06 µM-2.s-1 and 0.26 ± 0.023 µM-1.s-1 for k2 and k3 respectively. The 
experiments with Grx1 should ideally show similar values for k2, which is the rate constant 
for GSH oxidation. However, the predicted k2 values for our fitting experiments were 
different and these differences may be due to the differences in the datasets. For example, the 
GSH dataset was obtained from a reciprocal plot in the literature therefore leading to 
exaggerated errors following the conversions of these points (Fig. 3.8 C). Collectively, these 
fitting experiments showed that the dithiol mechanism was sufficient for describing 



























Figure 3.8. Comparison of the Saccharomyces cerevisiae kinetic model (continuous line) 
fitted to various in vitro (●) datasets . In (A), a Grx1 dithiol kinetic model was fitted to a 
HED dataset and the rate constants k2 and k3 were determined as                                   
4.23x10-06 ± 2.99x10-07 µM-2.s-1 and 0.07 ± 0.012 µM-1.s-1 respectively, while in (B) a Grx2 
kinetic model was fitted to a HED dataset and the rate constants were determined as             
k2 = 7.07x10
-05 ± 1.19x10-05 µM-2.s-1 and k3 = 0.30 ± 0.057 µM
-1.s-1 (Li et al., 2010). When a 
Grx1 dithiol kinetic model was fitted to a GSH dataset with a HED substrate (Discola et al., 
2009) the rate constants k2 and k3 were determined as 1.18x10
-05 ± 6.25x10-06 µM-2.s-1 and 






3.4 Discussion  
 
Both the dithiol and monothiol mechanisms have been proposed for 
deglutathionylation, with data supporting both mechanisms presented in the literature. 
Deciding which mechanism should be used in computational systems biology models has 
therefore been difficult. Further, a number of other discrepancies have been reported in vitro 
kinetic studies (Chapter 2).  
 
One of the major differences in the mono- and di- thiol mechanisms is that the GrxSSG 
mixed disulfide has been suggested to be the exclusive intermediate in the monothiol 
mechanism (Mieyal et al., 2008). The monothiol  mechanism also possesses a side reaction 
which includes the formation of the intramolecular disulfide GrxSS as another intermediate, 
which is assumed to detract from catalysis. Re-evaluation of both the dithiol and monothiol 
mechanisms showed that by including the side reaction in the monothiol mechanism and 
expanding the dithiol mechanism to include the transient GrxSSG mixed disulfide species in 
the basic structure of the mechanism, the two proposed mechanisms for deglutathionylation 
were identical (Fig. 3.3).  
 
Considering the proposed functional equivalence of the two mechanisms, a 
computational dithiol model was considered sufficient in describing deglutathionylation for 
computational systems biology. It should be noted that the GrxSSG mixed disulfide was not 
included in this model because the partitioning  to oxidised glutaredoxin (GrxSS) occurs 
rapidly as shown by trapping experiments (Peltoniemi et al., 2006). This computational 
dithiol model was confirmed by our computational experiments which showed results 
consistent with the in vitro data presented in the literature (Fig. 3.4; Peltoniemi et al., 2006) 
and was further able to fit a number of in vitro datasets. Furthermore, in a previous study, rate 
constants were determined for the deglutathionylation of PSSG by fitting kinetic model data 
to in vitro datasets reported by Peltoniemi et al., (2006). This fitting experiment showed an 
extremely good fit with an r2 value of 0.990 (Pillay et al., 2009) and the dithiol model was 
able to successfully predict two independent datasets. The results from the fitting experiments 
shown in this thesis and from the previous study showed that the dithiol mechanism could be 




Mathematical models were used to describe the contrasting differences in the activity 
of the active site glutaredoxin mutant and native glutaredoxins. These results revealed the 
basis for the differences in the activity of the wild-type and mutant glutaredoxins. It was 
shown that the relative activities of the wild-type and mutant glutaredoxins depended on the 
rate constants for GSH oxidation and on GSH concentration. The mathematical model 
predicted that the activity of the mutant and wild-type glutaredoxins would become 
equivalent under conditions of increased GSH concentrations which was confirmed by in 
vitro kinetic data (cf. Fig. 2.2; Gallogly et al., 2008).  
 
Computational models also revealed a ping-pong kinetic pattern for the two substrate 
kinetic analysis of glutathionylated substrate (PSSG) as anticipated (Yang et al., 1998). To 
understand the ping-pong behaviour, the standard ping-pong expression was compared to the 
kinetic rate expression determined or the wild-type glutaredoxin. It was shown that the 
gradient of the double-reciprocal plot for rate against PSSG was independent of the 
concentration of the substrate, which resulted in a characteristic ping-pong pattern (equation 
22). However, the double-reciprocal plot for rate against GSH resulted in a non-linear 
relationship with a concavely curved dependence. This reciprocal plot showed a quadratic 
relationship with 1/GSH (equation 8), and thus at low concentrations of GSH (high 1/GSH) 
these plots may appear linear, which was reported in some studies (Mieyal et al., 1991; 
Gravina and Mieyal, 1993; Mieyal et al., 1995; Gallogly et al., 2008). 
 
The literature also showed evidence of a sequential pattern when HEDS was used as a 
substrate for deglutathionylation (Mieyal et al., 1991; Mieyal et al., 1995). Our 
computational results showed that the sequential pattern was obtainable in a reciprocal plot if 
the reduction reaction of the substrate was modelled as a reversible reaction, providing a 
rational explanation in part for this effect. In conclusion we managed to resolve many of the 
discrepancies of the glutaredoxin activity described in the previous chapter and confirmed 
that the dithiol mechanism was sufficient in describing deglutathionylation in computational 




Chapter 4: General discussion and conclusion  
  
Glutaredoxins are important electron donors found in most living cells. During their 
catalytic cycles glutaredoxins become oxidized and are reduced by glutathione (GSH) and 
glutathione reductase (GLR) which collectively form the GSH/glutaredoxin system. The 
GSH/glutaredoxin system is a major regulator of the redox state of a number of a number of 
processes such as DNA synthesis, iron metabolism and iron-sulfur cluster assembly (Berndt et 
al., 2007). A key event in regulating the cellular response to oxidative stress is the formation 
of mixed disulfides between protein thiols and GSH in the glutathionylation process (Gravina 
and Mieyal, 1993). Numerous studies have shown that glutaredoxins can assist in the 
formation as well as the reduction of these mixed disulfides.  Under normoxic conditions, the 
reduction of mixed disulfides is usually favoured, but under severe oxidative stress conditions 
the GSH:GSSG ratio is decreased and mixed disulfide formation is favoured (Beer et al., 
2004). Glutathionylation is also induced by mild oxidative stress and this process is an 
important redox regulatory mechanism (Ruoppolo et al., 1997). 
 
The kinetic mechanism of glutaredoxin dependent deglutathionylation was not clear as 
glutaredoxins had been proposed to follow either a mono- or a di-thiol mechanism 
(Bushweller et al., 1992; Gallogly et al., 2007; Mieyal et al., 2008; Deponte, 2013). However, 
different structural properties were expected with computational systems biology models 
based on these mechanisms, and it was therefore likely that these models would produce 
different behaviours given the same set of input parameters. Moreover, the kinetic data 
supporting these mechanisms and describing glutaredoxin activity has also been extremely 
contradictory.  
 
Several studies have attempted to explain the discrepancies in the description of the 
mechanism for deglutathionylation (Mieyal et al., 2008; Gallogly et al., 2009; Deponte, 
2013). According to Deponte (2013) the dithiol and monothiol mechanisms cannot resolve 
these discrepancies of glutaredoxin activity. Consequently, two additional mechanisms were 
proposed, namely the glutathione scaffold model, which could explain why the monothiol 
glutaredoxins lacking activity in the HEDS assay were easily glutathionylated. The second 
model is the glutathione activator model which proposes an explanation for the sequential 
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kinetic pattern with the HEDS assay (Deponte, 2013).  The suggested models were however 
very confusing and no data was provided for these mechanisms.  
 
Using computational and mathematical models we were able to resolve these 
discrepancies. Firstly, and in contrast to the current thinking in this field, we showed that the 
mono- and di- thiol mechanisms were equivalent. Using a mathematical model we showed 
that the relative activity of mutant and wild-type glutaredoxins depended critically on the rate 
constant for GSH-oxidation and on the GSH concentration used in kinetic assays, which 
agreed with in vitro data (Srinivasan et al., 1997; Gallogly et al., 2009). To understand the 
contrasting reciprocal plot kinetics for glutaredoxins the mathematical model was modified 
and compared to the standard ping-pong kinetic expression. The results showed that a parallel 
line pattern was expected with a glutathionylated substrate but a curved line pattern would be 
obtained with increasing GSH concentrations. Kinetic modelling experiments also showed 
that a sequential pattern was obtainable when the reduction of the protein substrate was 
modelled with reversible kinetics. Collectively, these results together with the fitting 
experiments showed how deglutathionylation should be described in computational systems 









Figure 4.1. The formation of oxidized glutaredoxin in the presence of ROS may be a 
mechanism to prevent deglutathionylation by inactivating the glutaredoxin temporarily 
until activity is required (Mashamaite et al., 2015). 
 
The kinetic mechanism revealed a potentially interesting aspect of glutaredoxin 
regulation and our results support a previous study by Peltoniemi et al. (2006). In this study it 
was proposed that the intramolecular disulfide formation between the two cysteines of the 
active site of glutaredoxins protects these thiols against hyper-oxidation (Peltoniemi et al., 
2006). Under oxidative stress conditions the GSH/GSSG ratio decreases (Zitka et al., 2012), 
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this would leave the glutaredoxin trapped in the intramolecular disulfide (GrxSS) form. Once 
the stress was relieved, cellular GSH levels would increase and therefore active glutaredoxins 
will become available (Peltoniemi et al., 2006). We suggest that the formation of this oxidized 
glutaredoxin under relatively high GSSG and low GSH concentrations (Peltoniemi et al., 
2006) temporarily inactivates glutaredoxins, preventing deglutathionylation under oxidative 
stress conditions. Protein thiols which are glutathionylated are therefore not prematurely 
exposed to ROS. This potential regulatory mechanism for glutaredoxin activity shows that the 
formation of the oxidised glutaredoxin (GrxSS) (Fig. 4.1) may be an important cellular redox 
sensor and may therefore be used as a biomarker for oxidative stress. This biomarker has an 
advantage over GSH/GSSG measurements as it may be less affected by compartment mixing 
during cell lysis (Morgan et al., 2013).  
 
In summary, these results have shown that considering the dynamics of the 
glutaredoxin system as a whole, allows for better prediction of kinetic regulatory behaviours. 
It is anticipated that the computational modelling presented in this thesis will play an 
important part in further describing the dynamic behaviours of the glutaredoxin system. 
Having identified the mechanism that should be used in computational systems biology 
enables us to model and analyse glutathionylation and deglutathionylation in various systems. 
For example human Grx1 has been suggested to protect the endothelial cells against oxidative 
stress because its expression was found to be elevated in coronary arteries in normal and 
atherosclerotic vessels (Adluri et al., 2012) and Grx1 has also been shown to reduce the 
oxidant-induced cell death and apoptosis (Adluri et al., 2012). Glutathionylation has also been 
recognised as a signalling mechanism in cardiovascular disease and a number of studies have 
shown the importance of oxidative cysteine changes in controlling cardiovascular function 
(Pastore and Piemonte, 2013) but, the mechanism linking the inhibition of oxidative stress and 
the cardio-protective capabilities by Grx1 is unclear (Adluri et al., 2012).  
 
This regulatory mechanism proposed above (Fig. 4.1) could be used to analyse the 
cardiovascular system more effectively in order to understand the effects of ROS and redox 
imbalance contributing to the pathogenesis of many diseases occurring in the cardiovascular 
system as well as in many other systems (Hare and Stamler, 2005; Gallogly et al., 2009). 
However, further work is required to develop assays for oxidised glutaredoxin (GrxSS) and 
establish whether this is a viable cellular marker for oxidative stress. Evaluating the formation 
of GrxSS in vitro and in vivo will allow us to confirm the proposed protective abilities of this 
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species under oxidative stress conditions. Additionally, knowing how to describe 
deglutathionylation in computational systems biology means we are now able to develop 
computational models of real systems, enabling us to complement proteomic redox studies 
(Fratelli et al., 2002; Fratelli et al., 2004; Rouhier et al., 2004; Meyer et al., 2009). This could 
give us deeper insights into the glutathionylation/deglutathionylation cycle under 
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PySCeS code listings 
 
A1. Monothiol model 
 
FIX: PSSG PSH NADPH NADP  
 
R1: GSSG + NADPH = GSH + GSH + NADP 
kcat1*GR*GSSG*NADPH/(Kgssg*Knadph)/((1+GSSG/Kgssg)*(1+NADPH/Knadph))  
 
R2: GrxSSG + GSH = Grx(SH)2 + GSSG  
k2*GrxSSG*GSH*(1-((Grx(SH)2*GSSG/GrxSSG*GSH)/Keq2)) 
     




A2. Dithiol model  
 
FIX: PSSG PSH NADPH NADP GSHp 
 
R1: GSSG + NADPH = {2} GSH + NADP 
kcat1*GR*GSSG*NADPH/(Kgssg*Knadph)/((1+GSSG/Kgssg)*(1+NADPH/Knadph)) 
     
R2: GrxSS + {2} GSH = Grx(SH)2 + GSSG 
k2*((GrxSS*(GSH**2)) - (Grx(SH)2*GSSG)/Keq2) 
     










Table A1. Parameters and values for fitting Escherichia coli Grx1 substrate saturation 












Table A2. Parameters and values for fitting yeast Grx1 and Grx2 HEDS datasets of Li 
et al. 2010  
 
 
 Value  Reference 
Metabolite (µM)  
  NADPH 50 Peltoniemi et al., 2006 
  NADP 1 - 
  GSH 998 Peltoniemi et al., 2006 
  GSSG 1 Peltoniemi et al., 2006 
  PSSG 1 Peltoniemi et al., 2006 
  PSH 1 - 
Redoxin  (µM)  
  Grx(SH)2 0.01
 
Peltoniemi et al., 2006 
  GrxSS 0.01 Peltoniemi et al., 2006 
Glutathione reductase   
  KNADPH 3.8 µM Williams, 1976 
  KGSSG 55 µM Williams, 1976 
  k cat 500 s
-1 
Massey and Williams, 1965 
  [Glutathione reductase] 0.02 µM Peltoniemi et al., 2006 
   
 Value  Reference 
 Grx1 Grx2  
Metabolite (µM) (µM)  
  NADPH 250 250 Li et al., 2010 
  NADP 1 1 - 
  GSH 998 998 Li  et al ., 2010 
  GSSG 1 1 Li  et al ., 2010 
  PSSG 70 70 Li  et al ., 2010 
  PSH 1 1 - 
Redoxin  (µM) (µM)  
  Grx(SH)2 0.12 0.02 Li  et al ., 2010 
  GrxSS 0.12 0.02 Li  et al ., 2010 
Glutathione reductase    
  KNADPH 15 µM  15 µM  Yu and Zhou, 2007 
  KGSSG 74.6 µM  74.6 µM  Yu and Zhou, 2007 




 Yu and Zhou, 2007 
  [Glutathione reductase] 0.02 µM 0.02 µM Li  et al ., 2010 
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 Value  Reference 
Metabolite (µM)  
  NADPH 200 Discola et al., 2009 
  NADP 1 - 
  GSH 998 Discola et al., 2009 
  GSSG 1  
  PSSG 30 Discola et al., 2009 
  PSH 1 - 
Redoxin  (µM)  
  Grx(SH)2 0.25 Discola et al., 2009 
  GrxSS 0.25 Discola et al., 2009 
Glutathione reductase   
  KNADPH 15 µM Yu and Zhou, 2007 
  KGSSG 74.6 µM Yu and Zhou, 2007 
  k cat 900  s
-1
 Yu and Zhou, 2007 






1. Time course simulations 
 
import os 










from pylab import * 
 






m.doSim(end = 250, points = 100) 
f, c = m.data_sim.getSpecies(lbls=True) 
b = [] 
for i in range(len(c)-1): 
    b.append((c[i+1], i+1)) 
 
print '\nScan labels:\n' 
for i in range(len(b)): 
    print b[i] 
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pylab.rc('font', family = 'sans-serif') 
pylab.rc('xtick', labelsize = 10) 
pylab.rc('ytick', labelsize = 10) 
pylab.rc('ytick.major', pad = 8) 
pylab.rc('ytick.minor', pad = 8) 
pylab.rc('axes', labelsize = 12) 
pylab.rc('legend', fontsize = 12) 
pylab.rc('legend', axespad = 0.02) 




ax = fig.add_subplot(222) 
ax.plot(f[:,0], f[:,1], 'r--', label='GSSG' ) 
ax.plot(f[:,0], f[:,2], 'b-', label='GSH' ) 
ax.plot(f[:,0], f[:,3], 'b-', label='GrxSSGSH' ) 
ax.plot(f[:,0], f[:,4], 'r--', label='GrxSH2' ) 
plt.ylabel(r'[Species] ($\mu$M)') 




    pylab.draw() 
    pylab.savefig(name) 
 
if __name__ == "__main__": 
    draw() 
    show() 
    time.sleep(15) 
    pylab.close() 






2. Kinetic behaviour of the realistic dithiol model 
 
import os 
























# configure text stuff 
pylab.rc('font', family = 'sans-serif') 
pylab.rc('xtick', labelsize = 10) 
pylab.rc('ytick', labelsize = 10) 
pylab.rc('ytick.major', pad = 8) 
pylab.rc('ytick.minor', pad = 8) 
pylab.rc('axes', labelsize = 12) 
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pylab.rc('legend', fontsize = 12) 
#pylab.rc('legend', axespad = 0.02) 
#pylab.rc('legend', handletextsep = 0.05) 
 
# create da figure 
ioff() 
fig=pylab.figure() 
ax = fig.add_subplot(222) 
plt.ylabel(r'1/v (s.$\mu$M$^{-1}$)') 
plt.xlabel(r'1/PSSG ($\mu$M)$^{-1}$')  
ax.plot(o[:,0], o[:,1], 'k-', label='model' ) 
pylab.draw()     
 
def setFigLabels(x='X-axis', y='Y-axis'): 
    ax.set_xlabel(x) 
    ax.set_ylabel(y) 
 
def save_fig(name='PSSG_recip.png'): 
    pylab.draw() 
    pylab.savefig(name) 
     
if __name__ == "__main__": 
    draw() 
    show() 
    save_fig() 
    time.sleep(15) 
    pylab.close() 









3. Reciprocal kinetic plots 
 
import os 
















m.GSH_init = 0.25 
m.GSSG_init = 0 
m.scan_in= 'PSSG' 
m.scan_out= ['J_R1'] 





m.GSH_init = 0.3 









m.GSH_init = 0.4 







m.GSH_init = 0.6 











o.Keq2 = 100 
o.GSH_init = 0.25 
o.GSSG_init = 0 
o.scan_in= 'PSSG' 
o.scan_out= ['J_R1'] 









o.GSH_init = 0.3 







o.GSH_init = 0.4 







o.GSH_init = 0.6 







#~ # configure text stuff 
pylab.rc('font', family = 'sans-serif') 
pylab.rc('xtick', labelsize = 10) 
pylab.rc('ytick', labelsize = 10) 
pylab.rc('ytick.major', pad = 8) 
pylab.rc('ytick.minor', pad = 8) 
pylab.rc('axes', labelsize = 12) 
pylab.rc('legend', fontsize = 12) 
#pylab.rc('legend', axespad = 0.02) 




# create da figure 
ioff() 
fig=pylab.figure() 
ax = fig.add_subplot(221) 
 
ax.plot(h[:,0], h[:,1], 'k-', label='GSH=2' ) 
ax.plot(i[:,0], i[:,1], 'b-', label='GSH=3' ) 
ax.plot(k[:,0], k[:,1], 'r-', label='GSH=4' ) 
ax.plot(n[:,0], n[:,1], 'g-', label='GSH=5' ) 
ax.plot(x[:,0], x[:,1], 'k--', label='GSH=2' ) 
ax.plot(y[:,0], y[:,1], 'b--', label='GSH=3' ) 
ax.plot(w[:,0], w[:,1], 'r--', label='GSH=4' ) 
ax.plot(v[:,0], v[:,1], 'g--', label='GSH=5' ) 
#ax.legend(loc=4) 
#plt.xmin = 10 
plt.ylabel(r'v ($\mu$M$s^{-1})$')  
plt.xlabel(r'PSSG($\mu$M)')  
 
ax = fig.add_subplot(222) 
ax.plot(h[:,0], h[:,1], 'k-', label='GSH=2' ) 
ax.plot(i[:,0], i[:,1], 'b-', label='GSH=3' ) 
ax.plot(k[:,0], k[:,1], 'r-', label='GSH=4' ) 
ax.plot(n[:,0], n[:,1], 'g-', label='GSH=5' ) 
#ax.legend(loc=4) 
#plt.xmin = 10 




ax = fig.add_subplot(223) 
ax.plot(x[:,0], x[:,1], 'k--', label='GSH=2' ) 
ax.plot(y[:,0], y[:,1], 'b--', label='GSH=3' ) 
ax.plot(w[:,0], w[:,1], 'r--', label='GSH=4' ) 
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ax.plot(v[:,0], v[:,1], 'g--', label='GSH=5' ) 
#ax.legend(loc=4) 
#plt.xmin = 10 








    pylab.draw() 
    pylab.savefig(name) 
 
if __name__ == "__main__": 
    draw() 
    show() 
    save_fig() 
    time.sleep(15) 
    pylab.close() 
    os.chdir(backupdir) 
















4. Nonlinear least squares analysis of Discola (Grx1) data  
 
import os 









from pylab import * 
 
# get data 
f1a = numpy.loadtxt('peltp.csv')   # Grx (tot), J_R1 
 











# configure text stuff 
pylab.rc('font', family = 'sans-serif') 
pylab.rc('xtick', labelsize = 8) 
pylab.rc('ytick', labelsize = 10) 
pylab.rc('ytick.major', pad = 8) 
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pylab.rc('ytick.minor', pad = 8) 
pylab.rc('axes', labelsize = 12) 
pylab.rc('legend', fontsize = 12) 
#pylab.rc('legend', axespad = 0.02) 
#pylab.rc('legend', handletextsep = 0.05) 
##  pylab.rc('legend', labelsep = 0.02) 
##  pylab.rc('legend', pad = 0.3) 
 
# generate model data for fit conditions 
def genmodeldata(m, p, scanpar, xrange): 
    k2, k3 = p 
    m.k2 = k2 
    m.k3 = k3 
    m.scan_in = scanpar 
    m.scan_out = ['J_R1'] 
    m.Scan1(xrange) 
    return m.scan_res 
     
def residuals(p, expdata): 
    modeldata = genmodeldata(m, p, 'PSSG', expdata[:,0])[:,1] 
    err = expdata[:,1] - modeldata 
    return err 
 
def fitexp(expdata, p0, plot=0): 
    df = len(expdata)- len(p0) 
    ydata = expdata[:,1] 
    xdata = expdata[:,0] 
    SStot = sum((ydata-scipy.mean(ydata))**2)    
    plsq = scipy.optimize.leastsq(residuals, p0, args=(expdata), full_output=1) 
    pfit = plsq[0] 
    cov_x = plsq[1] 
    fin_residuals = plsq[2]['fvec'] 
    SSQ = sum((fin_residuals)**2) 
    SE = scipy.sqrt(SSQ/df*scipy.diag(cov_x)) 
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    SD = scipy.sqrt(SSQ/len(fin_residuals)) 
    Rsq = 1.0-SSQ/SStot 
    if plot: 
        mdata = genmodeldata(m, pfit, 'PSSG', scipy.linspace(xdata[0], xdata[-1], 100)) 
        plotdata(expdata, mdata) 
        print 'Rsq', Rsq 




ax = fig.add_subplot(222) 
plt.ylabel(r'$v$ ($\mu$M s$^{-1}$)') 
plt.xlabel(r'PSSG ($\mu$M$)$')  
pylab.draw()   
 
def plotdata(expdata, modeldata): 
 ax.plot(expdata[:,0], expdata[:,1], 'ko',label='data') 
 ax.plot(modeldata[:,0], modeldata[:,1], 'k-',label='model') 
 pylab.draw()     
 
def save_fig(name='Pelt_ePSSG.png'): 
    pylab.draw() 
    pylab.savefig(name)     
 
if __name__ == "__main__": 
    data1 = f1a 
    p0 = scipy.copy((m.k2, m.k3)) 
    fit1 = fitexp(data1, p0, plot=1) 
    print 'fitted values:' 
    print 'k2:    ', fit1['pfit'][0], ' +- ', fit1['SE'][0] 
    print 'k3:    ', fit1['pfit'][1], ' +- ', fit1['SE'][1] 
    save_fig() 
    pylab.close() 
    os.chdir(backupdir) 
